Pharmacokinetics of darifenacin extended-release tablets in healthy Chinese volunteers

LIU Yuan-yuan,HUANG Yan,DING Li,MAO Xiao-ming,WEN Ai-dong,YANG Lin

2009-01-01

Abstract:AIM To establish a liquid chromatography-electrospray ionization mass spectrometry (LC-MS) method for the concentration determination and pharmacokinetics of darifenacin in healthy volunteers plasma. METHODS After being treated with saturated sodium bicarbonate,the plasma sample was extracted by cyclohexane and determined by LC-MS; and then was separated on a Lichrospher C18 (150 mm × 2.1 mm,5 μm) column with a mobile phase of 40 mmol·L-1 ammonium containing 0.05% formic acid ∶ methanol (52 ∶ 48,V / V). The selected ion monitoring with the positive mode was applied in the LC-MS. RESULTS The calibration curve was linear over the range of 0.03 -20 μg·L-1. The lower limit of quantification was 0.03 μg·L-1. After taking the three separated single oral administrations of darifenacin extended-release tablets 7.5 mg,15 mg and 30 mg in 10 healthy volunteers,the main pharmacokinetic parameters were as follows:ρmax (1.8 ± s 0.6),(5.4 ± 2.4) and (15 ± 9) μg·L-1,AUC0-72 (33 ± 12),(100 ± 18) and (203 ± 71) μg·h·L-1,t1/2 (13 ± 9) ,(11 ± 5) and (12 ± 7) h,respectively. After a multiple oral administration of darifenacin extended-release tablets 15 mg,the steady-state plasma concentration of the drug was (6 ± 4) μg·L-1. No significant difference was shown in the ρmax,tmax,t1/2,MRT,CL ( F) ,AUC0 -72 between the 5 male and 5 female volunteers. CONCLUSION The established method is rapid,simple and sensitive,showing a non-linear characteristic pharmacokinetics at three different single dose in healthy Chinese subjects. The increase rates of AUC and ρmax of darifenacin were greater than those of the doses administered with no significant difference in the pharmacokinetic characterisitics between the male and female volunteers. An accumulation occurred after multiple administrations.